136 related articles for article (PubMed ID: 17211914)
1. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
Franke R; Hirsch T; Overwin H; Eichler J
Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914
[No Abstract] [Full Text] [Related]
2. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
3. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
Gabriel JL; Mitchell WM
Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation assists binding of HIV protein gp120 to human CD4 receptor.
Wilhelm D; Behnken HN; Meyer B
Chembiochem; 2012 Mar; 13(4):524-7. PubMed ID: 22266649
[TBL] [Abstract][Full Text] [Related]
6. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
[TBL] [Abstract][Full Text] [Related]
7. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
9. Small molecular CD4 mimics as HIV entry inhibitors.
Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
[TBL] [Abstract][Full Text] [Related]
10. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
Hsu ST; Bonvin AM
Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
[TBL] [Abstract][Full Text] [Related]
11. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
[TBL] [Abstract][Full Text] [Related]
12. Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold.
Azoitei ML; Correia BE; Ban YE; Carrico C; Kalyuzhniy O; Chen L; Schroeter A; Huang PS; McLellan JS; Kwong PD; Baker D; Strong RK; Schief WR
Science; 2011 Oct; 334(6054):373-6. PubMed ID: 22021856
[TBL] [Abstract][Full Text] [Related]
13. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains.
Wang JH; Yan YW; Garrett TP; Liu JH; Rodgers DW; Garlick RL; Tarr GE; Husain Y; Reinherz EL; Harrison SC
Nature; 1990 Nov; 348(6300):411-8. PubMed ID: 1701030
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of alpha-helical peptides and mimetics.
Garner J; Harding MM
Org Biomol Chem; 2007 Nov; 5(22):3577-85. PubMed ID: 17971985
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
[TBL] [Abstract][Full Text] [Related]
16. And the best picture is--the HIV gp120 envelope, please!
Berger EA
Nat Struct Biol; 1998 Aug; 5(8):671-4. PubMed ID: 9699624
[No Abstract] [Full Text] [Related]
17. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
Berkower I; Murphy D
Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
[TBL] [Abstract][Full Text] [Related]
18. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
[TBL] [Abstract][Full Text] [Related]
19. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.
Gopi HN; Tirupula KC; Baxter S; Ajith S; Chaiken IM
ChemMedChem; 2006 Jan; 1(1):54-7. PubMed ID: 16892335
[No Abstract] [Full Text] [Related]
20. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
